“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”
“I’ve worked with the RNA team on a number of valuation matters, large and small. These guys know their stuff. Whether using them to assist with large licensing transaction negotiations to simple tax and financial reporting work, they understand and they deliver.”
“The RNA team has been incredibly professional, very responsive to our on-going and sometimes tight turnaround valuation requests and has been an absolute pleasure to work with.”
“The RNA team is responsive and efficient and understands the nuances of valuation as pertains to our sector, and we valued our partnership with them.”
Enter your email address below to receive updates from RNA Advisors.
